Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1510.85 -5.30 (-0.35%) | NSE 1509.90 -7.10 (-0.47%) | Trade | Add

BSE Live

Jan 16, 16:01

1510.85 -5.30 (-0.35%)

Volume

AVERAGE VOLUME

5-Day

28,838

10-Day

23,496

30-Day

14,779

495,166

Prev. Close

1516.15
Open Price

1516.15

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 16, 15:55

1509.90 -7.10 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

429,775

10-Day

351,579

30-Day

253,304

107,415

Prev. Close

1517.00
Open Price

1512.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.27	25.27	25.24	25.24	25.24
Total Share Capital	25.27	25.27	25.24	25.24	25.24
Reserves and Surplus	3,590.27	3,097.12	2,663.33	2,430.02	2,233.95
Total Reserves and Surplus	3,590.27	3,097.12	2,663.33	2,430.02	2,233.95
Total Shareholders Funds	3,627.48	3,122.39	2,688.57	2,455.26	2,259.19
Minority Interest	13.63	15.54	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	102.97	140.85	234.01	351.74	484.27
Deferred Tax Liabilities [Net]	141.82	147.55	159.71	170.47	156.46
Other Long Term Liabilities	15.28	1.56	1.56	1.56	1.62
Long Term Provisions	32.23	25.28	25.88	24.55	20.22
Total Non-Current Liabilities	292.30	315.24	421.16	548.32	662.57
CURRENT LIABILITIES
Short Term Borrowings	310.95	209.69	239.04	177.30	184.85
Trade Payables	609.85	524.32	423.47	396.54	421.11
Other Current Liabilities	311.92	293.09	277.85	321.68	301.77
Short Term Provisions	93.70	70.40	67.21	60.41	62.22
Total Current Liabilities	1,326.42	1,097.50	1,007.57	955.93	969.95
Total Capital And Liabilities	5,259.83	4,550.67	4,117.30	3,959.51	3,891.71
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,922.45	1,746.47	1,853.61	1,913.40	1,941.89
Intangible Assets	73.84	146.71	52.15	22.67	25.09
Capital Work-In-Progress	70.80	36.09	41.79	62.10	93.61
Fixed Assets	2,129.57	1,959.51	1,978.76	2,030.72	2,095.72
Non-Current Investments	71.31	30.05	17.52	22.24	25.82
Deferred Tax Assets [Net]	2.01	1.84	1.74	0.00	0.00
Long Term Loans And Advances	99.41	117.01	110.48	95.36	70.35
Other Non-Current Assets	39.38	17.31	16.12	22.18	30.70
Total Non-Current Assets	2,404.12	2,172.92	2,171.82	2,217.70	2,269.79
CURRENT ASSETS
Current Investments	238.25	90.38	69.35	113.57	0.00
Inventories	1,323.12	1,072.50	880.59	882.22	837.42
Trade Receivables	895.20	681.51	602.27	500.16	445.87
Cash And Cash Equivalents	180.92	282.30	150.57	35.85	175.54
Short Term Loans And Advances	2.95	2.57	2.87	2.05	1.75
OtherCurrentAssets	215.27	248.49	239.83	207.96	161.34
Total Current Assets	2,855.71	2,377.75	1,945.48	1,741.81	1,621.92
Total Assets	5,259.83	4,550.67	4,117.30	3,959.51	3,891.71
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	198.98	165.30	81.44	88.61	114.95
BONUS DETAILS
Bonus Equity Share Capital	20.90	20.90	20.90	20.90	20.90
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	67.28	41.06	0.00
Non-Current Investments Unquoted Book Value	37.65	0.00	11.36	9.94	0.05
CURRENT INVESTMENTS
Current Investments Quoted Market Value	238.25	90.38	69.35	113.57	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00